AbClon Inc (174900) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.075x

Based on the latest financial reports, AbClon Inc (174900) has a cash flow conversion efficiency ratio of -0.075x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.18 Billion ≈ $-1.47 Million USD) by net assets (₩29.07 Billion ≈ $19.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

AbClon Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how AbClon Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AbClon Inc total liabilities for a breakdown of total debt and financial obligations.

AbClon Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AbClon Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited STU:2TZ	-0.009x
Matrix Concepts Holdings Bhd KLSE:5236	0.037x
Bajaj Consumer Care Limited NSE:BAJAJCON	0.131x
China Railway Harbin Group of Technology Corp. A SHG:688459	N/A
Shenzhen Water Planning & Design Institute Co. Ltd. SHE:301038	N/A
E&R Engineering TWO:8027	0.062x
BlackRock Utility & Infrastructure Trust NYSE:BUI	-0.010x
Zhejiang Gongdong Medical Technology Co Ltd SHG:605369	0.034x

Annual Cash Flow Conversion Efficiency for AbClon Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of AbClon Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see AbClon Inc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩29.41 Billion ≈ $19.93 Million	₩-14.39 Billion ≈ $-9.75 Million	-0.490x	-40.56%
2023-12-31	₩27.23 Billion ≈ $18.46 Million	₩-9.48 Billion ≈ $-6.43 Million	-0.348x	-70.15%
2022-12-31	₩36.60 Billion ≈ $24.81 Million	₩-7.49 Billion ≈ $-5.08 Million	-0.205x	+54.15%
2021-12-31	₩19.36 Billion ≈ $13.12 Million	₩-8.64 Billion ≈ $-5.86 Million	-0.446x	-131.82%
2020-12-31	₩29.33 Billion ≈ $19.88 Million	₩-5.65 Billion ≈ $-3.83 Million	-0.193x	-1414.49%
2019-12-31	₩35.38 Billion ≈ $23.98 Million	₩-449.88 Million ≈ $-304.88K	-0.013x	-106.40%
2018-12-31	₩18.70 Billion ≈ $12.67 Million	₩3.71 Billion ≈ $2.52 Million	0.199x	+409.96%
2017-12-31	₩17.39 Billion ≈ $11.79 Million	₩-1.11 Billion ≈ $-755.45K	-0.064x	-274.68%
2016-12-31	₩11.98 Billion ≈ $8.12 Million	₩-204.92 Million ≈ $-138.87K	-0.017x	+89.66%
2015-12-31	₩13.31 Billion ≈ $9.02 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.165x	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$635.95 Million

₩938.42 Billion KRW

Market Cap Rank

#11309 Global

#346 in Korea

Share Price

₩49150.00

Change (1 day)

-2.48%

52-Week Range

₩9630.00 - ₩89100.00

All Time High

₩90600.00